GlassScriptPhysician profile
Allen L Yeilding
NPI 1164443792
$35,992.88
in general payments reported to CMS, 2019-2025
90 companies · $6,430 in 2025
The $6,430 reported for 2025 was more than what 84% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,811 · 2020: $3,338 · 2021: $3,980 · 2022: $5,650 · 2023: $5,794 · 2024: $5,991 · 2025: $6,430.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16K · Long Term Medical Supply Or Device Loan: $2,250 · Education: $71.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15,893.70 |
| Long Term Medical Supply Or Device Loan | $2,249.91 |
| Education | $71.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $6,476.49 | 2019-2025 | |
| Pfizer INC. | $2,343.12 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $1,984.83 | 2019-2025 | Opdivo, Opdualag, Krazati |
| Mckesson Specialty Care Distribution, LLC | $1,527.38 | 2019-2020 | |
| Janssen Biotech, INC. | $1,441.86 | 2019-2025 | Darzalex, Rybrevant, Talvey |
| Merck Sharp & Dohme LLC | $1,347.06 | 2019-2025 | Keytruda, Welireg, Lynparza |
| Celgene Corporation | $1,126.60 | 2019-2025 | Reblozyl, Pomalyst, Opdualag |
| Eisai INC. | $1,101.35 | 2019-2025 | |
| Amgen INC. | $1,062.18 | 2019-2023 | Kyprolis, Blincyto |
| US Oncology Corporate, INC. | $1,046.85 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $891.00 | 2019-2025 | Imfinzi, Enhertu, Calquence |
| Genentech USA, INC. | $863.58 | 2019-2024 | Lunsumio, Polivy, Tecentriq |
| Csl Behring | $782.77 | 2019-2025 | Hizentra |
| Seagen INC. | $743.24 | 2019-2023 | Tukysa, Padcev, Adcetris |
| Takeda Pharmaceuticals U.S.A., INC. | $726.40 | 2019-2025 | Ninlaro, Fruzaqla, Iclusig |
Show all 90 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Delcath Systems | $697.68 | 2024-2025 | Hepzato Kit |
| Abbvie INC. | $667.61 | 2019-2025 | Creon |
| Daiichi Sankyo INC. | $663.68 | 2019-2025 | Enhertu, Datroway |
| Lilly USA, LLC | $641.50 | 2019-2025 | Jaypirca, Verzenio, Retevmo |
| Incyte Corporation | $596.50 | 2019-2025 | Jakafi, Monjuvi, Pemazyre |
| Genzyme Corporation | $521.07 | 2019-2025 | |
| Glaxosmithkline, LLC. | $402.33 | 2019-2025 | Ojjaara, Jemperli, Blenrep |
| Regeneron Healthcare Solutions, INC. | $361.72 | 2019-2025 | Libtayo, Lynozyfic |
| Octapharma USA, INC. | $358.10 | 2020-2021 | |
| Alexion Pharmaceuticals, INC. | $337.08 | 2019-2025 | Ultomiris, Soliris |
| Kite Pharma, INC. | $293.87 | 2020-2025 | Yescarta |
| Bayer Healthcare Pharmaceuticals INC. | $288.51 | 2019-2025 | |
| Beigene USA, INC. | $282.97 | 2020-2025 | Brukinsa, Tevimbra |
| Deciphera Pharmaceuticals INC. | $282.30 | 2021-2025 | Qinlock, Romvimza, Tgct |
| Gilead Sciences, INC. | $263.63 | 2019-2025 | Trodelvy |
| Stemline Therapeutics INC. | $229.60 | 2023-2025 | Orserdu, Elzonris |
| Intera Oncology, INC | $223.00 | 2023 | Intera 3000 Implantable Pump |
| Pharmacyclics LLC, An Abbvie Company | $222.26 | 2019-2023 | Imbruvica |
| Puma Biotechnology, INC. | $220.26 | 2019-2025 | |
| Astellas Pharma US INC | $217.82 | 2021-2025 | Xtandi, Padcev, Xospata |
| Blueprint Medicines Corporation | $208.24 | 2020-2024 | Ayvakit |
| Rigel Pharmaceuticals, INC. | $201.25 | 2019-2025 | Rezlidhia, Tavalisse, Tavalisse |
| Jazz Pharmaceuticals INC. | $194.66 | 2020-2025 | |
| Servier Pharmaceuticals LLC | $189.43 | 2023-2025 | |
| Kyowa Kirin, INC. | $185.47 | 2019-2020 | |
| Exelixis INC. | $172.72 | 2019-2025 | Cabometyx |
| Ipsen Biopharmaceuticals, INC | $159.25 | 2020-2024 | Onivyde, Somatuline Depot |
| Taiho Oncology, INC. | $153.17 | 2019-2025 | |
| Janssen Scientific Affairs, LLC | $149.66 | 2025 | Darzalex, Talvey, Carvykti |
| Emd Serono, INC. | $145.87 | 2019-2024 | Bavencio |
| Boehringer Ingelheim Pharmaceuticals, INC. | $144.64 | 2020-2025 | Gilotrif |
| Karyopharm Therapeutics INC. | $144.34 | 2020-2024 | Xpovio |
| Myriad Genetic Laboratories, INC. | $141.57 | 2021-2024 | Bracanalysis Cdx |
| Sobi, INC | $134.46 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $133.83 | 2023-2025 | Orgovyx |
| Onmark, INC. | $121.64 | 2023 | |
| Morphosys, US INC. | $121.26 | 2021-2023 | Monjuvi |
| Pharmacosmos Therapeutics INC. | $118.57 | 2021-2025 | Monoferric |
| Shield Therapeutics INC | $114.54 | 2023-2025 | Accrufer |
| Array Biopharma INC | $99.23 | 2022-2024 | Braftovi, Lorbrena, Mektovi |
| Cardinal Health 108 LLC | $97.43 | 2023 | |
| Global Blood Therapeutics, INC. | $97.16 | 2020-2022 | |
| Epizyme, INC. | $95.07 | 2022 | |
| Aveo Pharmaceuticals, INC. | $88.66 | 2022 | |
| Adc Therapeutics America, INC. | $88.58 | 2022-2024 | |
| Tersera Therapeutics LLC | $81.22 | 2024-2025 | Quzyttir |
| Beone Medicines USA, INC. | $80.48 | 2025 | Brukinsa, Tevimbra |
| Coherus Oncology, INC. | $77.58 | 2023-2025 | Loqtorzi |
| Janssen Pharmaceuticals, INC | $75.87 | 2019-2020 | |
| Mirati Therapeutics, INC. | $72.28 | 2023 | Krazati |
| Apellis Pharmaceuticals, INC. | $70.20 | 2023-2024 | Empaveli |
| Clovis Oncology, INC. | $56.37 | 2019-2020 | |
| Dova Pharmaceuticals | $54.78 | 2019-2020 | |
| Tempus Ai, INC | $53.86 | 2024 | |
| Genmab U.S., INC. | $51.37 | 2023-2024 | Epkinly |
| Recordati_rare_diseases_inc. | $44.83 | 2025 | Sylvant |
| Acrotech Biopharma INC. | $44.47 | 2022-2025 | Beleodaq |
| Progenics Pharmaceuticals, INC. | $43.38 | 2022 | |
| Hema Biologics, LLC | $42.14 | 2023 | Sevenfact |
| Adaptive Biotechnologies Corporation | $40.40 | 2023-2024 | Clonoseq |
| Pharmaessentia USA Corporation | $38.79 | 2024-2025 | Besremi |
| Tesaro, INC. | $35.27 | 2019 | |
| Sanofi-Aventis U.S. LLC | $34.10 | 2020-2021 | |
| Myovant Sciences INC. | $33.88 | 2022 | |
| Springworks Therapeutics, INC. | $33.59 | 2024-2025 | Ogsiveo |
| Novocure INC. | $29.60 | 2020-2025 | Optune Lua (Novottf-200t) |
| Eusa Pharma (US) LLC | $26.83 | 2021 | |
| Geron Corporation | $25.50 | 2025 | Rytelo |
| Accord Healthcare, INC. | $21.06 | 2023 | |
| Shire North American Group INC | $20.46 | 2019 | |
| Sandoz INC. | $14.58 | 2020 | |
| Secura Bio, INC. | $14.29 | 2020 | |
| Verastem, INC. | $13.75 | 2019 | |
| Mylan Institutional INC. | $13.48 | 2022 | |
| Collegium Pharmaceutical, INC. | $11.57 | 2020 |
Drugs and devices associated with these payments
Kisqali $2,599Hepzato Kit $698Hizentra $578Reblozyl $538Darzalex $485Lenvima $450Xtandi $449Opdivo $432Enhertu $406Orgovyx $360Talvey $333Tecvayli $323Keytruda $312Adcetris $310Elrexfio $305Jaypirca $280Verzenio $280Padcev $280Imfinzi $255Libtayo $242Carvykti $241Talzenna $239Ninlaro $234Rybrevant $225Intera 3000 Implantable Pump $223Qinlock $220Imbruvica $215Ojjaara $213Scemblix $213Orserdu $204Pluvicto $199Lutathera $187Jakafi $186Tukysa $181Ayvakit $177Brukinsa $172Inlyta $163Bosulif $161Oxbryta $160Ibrance $154Venclexta $152Fabhalta $148Fruzaqla $147Lunsumio $146Polivy $146Opdualag $144Sarclisa $140Tecentriq $135Monjuvi $130Nubeqa $130Epkinly $129Ultomiris $125Columvi $124Tivdak $117Accrufer $115Soliris $114Tavalisse $114Rezlidhia $114Krazati $113Iclusig $103Creon $102Trodelvy $101Voranigo $99.04Cabometyx $99.04Bavencio $97.45Promacta $95.69Piqray $95.02Xofigo $91.18Romvimza $85.93Quzyttir $81.22Zepzelca $79.91Tasigna $77.41Tibsovo $74.92Jemperli $73.85Retevmo $73.01Mekinist $72.92Pomalyst $70.37Empaveli $70.20Lynparza $69.88Pemazyre $66.33Erleada $64.94Monoferric $60.71Gilotrif $59.06Tevimbra $58.93Yescarta $53.52Lorbrena $52.90Comirnaty $51.81Udenyca $51.08Hympavzi $50.84Welireg $50.33Onivyde $49.54Somatuline Depot $49.54Akeega $47.06Blenrep $46.76Sylvant $44.83Datroway $44.64Sevenfact $42.14Elahere $42.02Elitek $41.65Clonoseq $40.40
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allen Yeilding listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.